BeiGene
BeiGene (Beijing) Co., Ltd. is a life sciences biotechnology company
2164 employees · est. 2010 · Cambridge, United States
Ipsen
Engineers and develops bacterial-based protein therapeutics for the treatment of neurological, inflammatory and endocrine diseases
6518 employees · est. 2010 · Paris, France
Ipsen is the larger of the two.
Side-by-Side Comparison
| Metric | BeiGene | Ipsen |
|---|---|---|
| Founded | ||
| Founded | 2010 | 2010 |
| Headquarters | ||
| Headquarters | Cambridge, United States | Paris, France |
| Employees | ||
| Employees | 2164 | 6518 larger |
| Industry | ||
| Industry | Not tracked yet | Biotechnology, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | IPO | Acquired |
| Total Funding | ||
| Total Funding | $6.69B | $277.40M |
| Funding Rounds | ||
| Funding Rounds | 9 | 4 |
| Services | ||
| Services | Cancer Treatment Development, Clinical Research and Trials, Patient Assistance Programs, Biopharmaceutical Manufacturing | Research and development, Pharmaceutical commercialization, Clinical trial execution, Therapeutic innovation |
| Target Customers | ||
| Target Customers | Cancer Patients, Healthcare Providers, Medical Researchers, Investors | Patients with oncology needs, Individuals living with rare diseases, Patients with neurodegenerative conditions, Healthcare providers, Pharmaceutical and biotech partners |
| Taxonomy | ||
| Taxonomy | Life Sciences, Innovative Medicines, Cancer Treatment, Immuno-oncology, Hematology, Oncology, Targeted Therapy, Global Rebranding, Patient Partnerships, Pharmaceutical Development, Therapeutic Innovation, Global Healthcare, Redomiciliation, Shareholder Engagement | Bacterial-based Protein Therapeutics, Neurological Diseases, Inflammatory Diseases, Endocrine Diseases, Oncology, Rare Disease, Neuroscience, Prostate Cancer, Neuroendocrine Tumors, Renal Cell Carcinoma, Pancreatic Cancer, Peptide Research, Toxin Research, External Innovation, Specialty Care |
| Website | ||
| Website | beonemedicines.com | ipsen.com |
About BeiGene
BeiGene, now rebranding as BeOne Medicines Ltd., is a notable player in the life sciences biotechnology sector. Founded in 2010, the company has been instrumental in developing innovative cancer therapies. The company recently changed the name of its U.S. subsidiary to BeOne Medicines USA, Inc. as...
About Ipsen
Ipsen, founded in 2010, is a global biopharmaceutical company headquartered in France. The company specializes in engineering and developing bacterial-based protein therapeutics aimed at treating neurological, inflammatory, and endocrine diseases. Focusing on three critical therapeutic areas—Oncolo...
We will tell you when either one moves
BounceWatch watches BeiGene and Ipsen for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at BeiGene and Ipsen — by email.
Frequently Asked Questions
Compare BeiGene with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at BeiGene on 11 Mar 2026, and Ipsen on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.